Line 156: | Line 156: | ||
<tr><td colspan=3 align=center valign=center> | <tr><td colspan=3 align=center valign=center> | ||
− | |||
<p> | <p> | ||
Our project, which we dubbed Cas13a controlled assay for infectious diseases (CascAID) features the recently identified CRISPR/Cas effector Cas13a. Unlike other proteins in the familiy, Cas13a has the unique ability to bind and cleave specific RNA targets rather than DNA ones. Moreover after cleaving its target, Cas13a presents collateral activity i.e. it can unspecifically cleave RNA molecules. By using Cas13a, our system can detect virtually detect any RNA target. This is done by changing the crRNA in the protein, that is a short RNA sequence that determines what is recognized as target. | Our project, which we dubbed Cas13a controlled assay for infectious diseases (CascAID) features the recently identified CRISPR/Cas effector Cas13a. Unlike other proteins in the familiy, Cas13a has the unique ability to bind and cleave specific RNA targets rather than DNA ones. Moreover after cleaving its target, Cas13a presents collateral activity i.e. it can unspecifically cleave RNA molecules. By using Cas13a, our system can detect virtually detect any RNA target. This is done by changing the crRNA in the protein, that is a short RNA sequence that determines what is recognized as target. | ||
+ | </p> | ||
+ | </td> | ||
+ | </tr> | ||
+ | |||
+ | <tr><td colspan=3 align=center valign=center> | ||
+ | <p> | ||
+ | To couple CascAID with an easy read-out method we explored three colorimetric read-outs: | ||
+ | <ul> | ||
+ | <li>AeBlue: The RNA strand in an specially designed RNA/DNA dimer is cut by Cas13a's collateral activity. After digestion, the interaction between the two strands is too weak to hold the dimer and it decays. We can then use the DNA-strand as template to transcribe the chromoprotein aeBlue. </li> | ||
+ | |||
+ | <li>Intein-Extein: </li> | ||
+ | |||
+ | <li>Gold nanoparticles:</li> | ||
+ | </ul> | ||
</p> | </p> | ||
</td> | </td> |
Revision as of 14:16, 4 October 2017